ORGANOGENESIS HOLDINGS INC. Investment Income, Interest and Dividend
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Investment Income, Interest and Dividend of $800.14 thousand for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2018-03-14
- ORGANOGENESIS HOLDINGS INC. investment income, interest and dividend for the quarter ending 2017-12-31 was $800.14K.
- ORGANOGENESIS HOLDINGS INC. investment income, interest and dividend for the quarter ending 2017-09-30 was $736.13K.
- ORGANOGENESIS HOLDINGS INC. investment income, interest and dividend for the quarter ending 2017-06-30 was $602.14K.
- ORGANOGENESIS HOLDINGS INC. investment income, interest and dividend for the quarter ending 2017-03-31 was $359.51K.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2017-12-31 | $800.14K 10-K · filed 2018-03-14 | $1.54M derived: sum of 2 quarters · filed 2018-03-14 | $2.14M derived: sum of 3 quarters · filed 2018-03-14 | $2.50M derived: sum of 4 quarters · filed 2018-03-14 |
| 2017-09-30 | $736.13K 10-K · filed 2018-03-14 | $1.34M derived: sum of 2 quarters · filed 2018-03-14 | $1.70M derived: sum of 3 quarters · filed 2018-03-14 | |
| 2017-06-30 | $602.14K 10-K · filed 2018-03-14 | $961.65K derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2017-03-31 | $359.51K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |